Kamran Alam, CHIEF FINANCIAL OFFICER at Taysha Gene Therapies, Inc. (TSHA), sold 108,982 shares at $2.85 ($311K) on 2025-08-21, disclosed to the SEC on 2025-08-22.
Seasonal sale ($311k) by CHIEF FINANCIAL OFFICER — this insider has traded TSHA in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 54,491 | $155K | 50.0% |
| 2 | $2.85 | 54,491 | $155K | 50.0% |
| Total | $2.85 avg | 108,982 | $311K | 100% |
| Filing → |
| TSHA | SELL | 2023-08-25 | $77K | — | Filing → |
| TSHA | SELL | 2022-08-24 | $12K | — | Filing → |
| TSHA | SELL | 2022-08-22 | $106K | — | Filing → |